OR4Q3
Olfactory receptor 4Q3
Also known as: OR4Q3_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- Q8NH05
- Gene
- OR4Q3
- Canonical length
- 313 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
No narrative summary is available for OR4Q3 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
313 residues, UniProt reviewed canonical sequence.
>Q8NH05|OR4Q3
1 MKKEQDSNVT EFVLLGLSSS WELQLFLFLL FLFFYIAIVL GNLLIVVTVQ AHAHLLQSPM
61 YYFLGHLSFI DLCLSCVTVP KMLGDFLQQG KSISFSGCLA QIYFLHFLGA SEMFLLTVMA
121 YDRYVAICNP LRYLTVMNPQ LCLWLVLACW CGGFIHSIMQ VILVIQLPFC GPNELDNFYC
181 DVPQVIKLAC MDTYVVEVLV IANSGLLSLV CFLVLLFSYA IILITLRTHF CQGQNKVFST
241 CASHLTVVSL IFVPCVFIYL RPFCSFSVDK IFSLFYTVIT PMLNPLIYTL RNTDMKTAMK
301 KLRIKPCGIP LPCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OR4Q3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 0.1 nTPM
Expression across tissuesHPA
Tissue
- testis: 0.1 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
- amygdala: 0 nTPM
- appendix: 0 nTPM
- basal ganglia: 0 nTPM
Single-cell type
- adipocytes: 0 nCPM
- adrenal cortex cells: 0 nCPM
- adrenal medulla cells: 0 nCPM
- alveolar cells type 1: 0 nCPM
- alveolar cells type 2: 0 nCPM
- astrocytes: 0 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 0.7 nTPM
- cerebral cortex: 0.5 nTPM
- basal ganglia: 0.4 nTPM
- medulla oblongata: 0.4 nTPM
- pons: 0.4 nTPM
- amygdala: 0.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.93
- gnomAD pLI
- 0
- gnomAD missense Z
- -3.1
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OR4Q3 as an antibody target. Whether an autoantibody or antibody against OR4Q3 could matter depends on whether native OR4Q3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OR4Q3 is annotated at the cell surface, where native OR4Q3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label OR4Q3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...